Most and least shorted mid- to mega-cap healthcare stocks at the end of May
Source: SeekingAlpha
2026-06-03 09:35:45 ET
- BeOne Medicines AG (ONC) Discusses Solid Tumor Portfolio Progress and R&D Pipeline Strategy at ASCO Transcript
- Bausch + Lomb Corporation (BLCO) Discusses Project Halo and Myopia Control Developments in Vision Care Transcript
- Bausch + Lomb Corporation (BLCO) Discusses Project Halo and Myopia Control Developments in Vision Care - Slideshow
- J&J lupus drug meets primary endpoint in Phase 2 study
- Draft FDA guidance could be a boon for gene therapy developers
Read the full article on Seeking Alpha
For further details see:
Most and least shorted mid- to mega-cap healthcare stocks at the end of May
Recursion Pharmaceuticals Inc.
NASDAQ: RXRX
RXRX Trading
15.85% G/L:
$3.91 Last:
28,185,858 Volume:
$3.44 Open:
RXRX Latest News
June 02, 2026 05:32:15 pm
Recursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026?
May 25, 2026 07:50:00 pm
Recursion Pharmaceuticals Just Hit a 52-Week Low. Is This Former Nvidia Holding a Smart Buy Now?
RXRX Stock Data
$2,001,374,702
484,488,629
1.68%
137
N/A
Biotechnology & Life Sciences
Healthcare
US
Salt Lake City
